Skip to main content
OpenTrials

Clinical trial condition

Oligodendroglioma

Explore clinical trials studying Oligodendroglioma. Study availability and eligibility vary by location and protocol.

40 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Oligodendroglioma trial results

Not yet recruiting

Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease

NCT07703436

Conditions
Astrocytoma IDH Mutant Grade 2, Astrocytoma IDH Mutant Grade 3, Glioma, +12 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
  • NYU Langone Health New York, United States
View Trial Details
Active, not recruiting

Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma

NCT03180502

Conditions
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Boca Raton Regional Hospital Boca Raton, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Emory Proton Therapy Center Atlanta, Georgia, United States
View all 34 locations
View Trial Details
Active, not recruiting

Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma

NCT05484622

Conditions
Astrocytoma, Glioma, Neoplasms, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles (Site: 840113) Los Angeles, California, United States
  • University of California, San Francisco (Site: 840149) San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 17 locations
View Trial Details

Related conditions